deferoxamine and cycloheximide

deferoxamine has been researched along with cycloheximide in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19902 (7.14)18.7374
1990's12 (42.86)18.2507
2000's10 (35.71)29.6817
2010's2 (7.14)24.3611
2020's2 (7.14)2.80

Authors

AuthorsStudies
Adams, RL; Baker, GM; Littleton, RJ; Soomro, IN; Whimster, WF1
Casey, JL; Harford, JB; Horowitz, JA; Klausner, RD; Koeller, DM1
DeFalco, MG; Giffhorn-Katz, S; Grasso, JA; Katz, NR; Liem, HH; Muller-Eberhard, U1
Chu, LL; Fineberg, RA1
Henderson, BR; Kühn, LC1
Bhattacharyya-Pakrasi, M; Gang, H; Goessling, LS; Mascotti, DP; Thach, RE1
Torti, FM; Torti, SV; Warren, S1
Henderson, BR; Kühn, LC; Menotti, E1
Ebert, BL; Nagao, M; Pugh, CW; Ratcliffe, PJ1
Eckardt, KU; Gess, B; Göpfert, T; Kurtz, A1
Bouton, C; Drapier, JC; Oliveira, L1
Acosta, M; Ames, BN; Bartholomew, JC; Campisi, J; Chen, QM; Reagan, JD1
Lu, Z; McLaren, RS; Ralston, E; Winters, CA1
Daghman, NA; Lappin, TR; Maxwell, AP; McHale, CM; Price, S; Savage, GM; Winter, PC1
Arkan, MC; Başağa, H; Biasi, F; Leonarduzzi, G; Poli, G1
Dirnagl, U; Isaev, N; Karsch, M; Megow, D; Meisel, A; Prass, K; Priller, J; Ruscher, K; Scharff, A1
Cui, XF; Hatakeyama, M; Imaizumi, T; Kimura, D; Kumagai, M; Matsumiya, T; Sakaki, H; Sato, Y; Satoh, K; Shibata, T; Tamo, W; Tanji, K; Yoshida, H1
Becker, I; Giffhorn-Katz, S; Immenschuh, S; Katz, N; Ohlmann, A1
Park, SW; Wei, LN1
Ann, DK; Bertolami, CN; Kelly, AP; Le, AD; Messadi, DV; Tuan, TL; Wu, Y; Zhang, Q1
Dringen, R; Hoepken, HH; Korten, T; Robinson, SR1
Harish Kumar, M; Maruyama, M; Omura, S; Radha, KS; Sugiki, M1
Autelli, R; Baccino, FM; Bonelli, G; Crepaldi, S; De Stefanis, D; Parola, M1
Imaizumi, T; Kimura, H; Kobayashi, W; Kubota, K; Kusumi, A; Matsumiya, T; Nakagawa, H; Sakaki, H1
Beart, PM; Chu, PW; Jones, NM1
Baccino, FM; Bonelli, G; Costelli, P; Khadjavi, A; Minero, VG1
Cho, SS; Ki, SH; Kim, KM1
Knopf, JD; Lemberg, MK; Link, C; Marques, O; Muckenthaler, MU1

Reviews

1 review(s) available for deferoxamine and cycloheximide

ArticleYear
Emerging roles of ferroptosis in liver pathophysiology.
    Archives of pharmacal research, 2020, Volume: 43, Issue:10

    Topics: Animals; Antineoplastic Agents; Caffeic Acids; Carcinoma, Hepatocellular; Cycloheximide; Cyclohexylamines; Deferoxamine; Disease Models, Animal; Disease Progression; Fatty Acids, Unsaturated; Ferroptosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Spiro Compounds

2020

Other Studies

27 other study(ies) available for deferoxamine and cycloheximide

ArticleYear
Kinetic aspects of Ki-67 antigen expression in a normal cell line.
    Virchows Archiv. B, Cell pathology including molecular pathology, 1991, Volume: 60, Issue:1

    Topics: Blood; Cell Cycle; Cell Division; Cell Line; Cycloheximide; Deferoxamine; Embryo, Mammalian; G1 Phase; Humans; Ki-67 Antigen; Kinetics; Neoplasms; Nuclear Proteins; Resting Phase, Cell Cycle; S Phase

1991
Translation and the stability of mRNAs encoding the transferrin receptor and c-fos.
    Proceedings of the National Academy of Sciences of the United States of America, 1991, Sep-01, Volume: 88, Issue:17

    Topics: Animals; Cell Line; Cycloheximide; Dactinomycin; Deferoxamine; Hemin; Humans; Mice; Plasmids; Protein Biosynthesis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogenes; Receptors, Transferrin; RNA, Messenger; Transfection

1991
Increase in surface expression of transferrin receptors on cultured hepatocytes of adult rats in response to iron deficiency.
    The Journal of biological chemistry, 1988, Oct-15, Volume: 263, Issue:29

    Topics: 5-Aminolevulinate Synthetase; Animals; Cells, Cultured; Cycloheximide; Deferoxamine; Heme; Heptanoates; Kinetics; Liver; Mannans; Rats; Receptors, Transferrin; Reference Values

1988
On the mechanism of iron-induced synthesis of apoferritin in HeLa cells.
    The Journal of biological chemistry, 1969, Jul-25, Volume: 244, Issue:14

    Topics: Antibodies; Carbon Isotopes; Cycloheximide; Dactinomycin; Deferoxamine; Ferritins; HeLa Cells; Humans; Iron; Iron Isotopes; Leucine; Phenanthrolines; Time Factors

1969
Differential modulation of the RNA-binding proteins IRP-1 and IRP-2 in response to iron. IRP-2 inactivation requires translation of another protein.
    The Journal of biological chemistry, 1995, Sep-01, Volume: 270, Issue:35

    Topics: 3T3 Cells; Animals; Cycloheximide; Cytidine Triphosphate; Dactinomycin; Deferoxamine; Iron; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Iron-Regulatory Proteins; Kinetics; L Cells; Melanoma, Experimental; Mercaptoethanol; Mice; Models, Structural; Protein Biosynthesis; RNA; RNA-Binding Proteins; Transcription, Genetic; Tumor Cells, Cultured

1995
Irreversible steps in the ferritin synthesis induction pathway.
    The Journal of biological chemistry, 1994, Feb-11, Volume: 269, Issue:6

    Topics: Animals; Cell Line; Cycloheximide; Deferoxamine; Ferritins; Heme; In Vitro Techniques; Iron; Iron-Regulatory Proteins; Rabbits; RNA-Binding Proteins; Time Factors

1994
The role of iron in the cytotoxicity of tumor necrosis factor.
    Lymphokine and cytokine research, 1993, Volume: 12, Issue:2

    Topics: Animals; Cell Death; Cell Line; Cycloheximide; Cytotoxicity, Immunologic; Deferoxamine; Drug Synergism; Fibroblasts; Iron; Mice; Tumor Necrosis Factor-alpha

1993
Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences.
    The Journal of biological chemistry, 1996, Mar-01, Volume: 271, Issue:9

    Topics: Animals; Base Sequence; Binding Sites; Cell Line; Cycloheximide; Deferoxamine; HeLa Cells; HL-60 Cells; Humans; Iron; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Iron-Regulatory Proteins; Melanoma, Experimental; Mice; Molecular Sequence Data; Nucleic Acid Conformation; Protein Structure, Secondary; RNA Probes; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Messenger; Substrate Specificity; Tumor Cells, Cultured

1996
Drosophila melanogaster SL2 cells contain a hypoxically inducible DNA binding complex which recognises mammalian HIF-binding sites.
    FEBS letters, 1996, Jun-03, Volume: 387, Issue:2-3

    Topics: Animals; Base Sequence; Binding Sites; Cell Hypoxia; Cell Line; Cobalt; Cycloheximide; Deferoxamine; Dithiothreitol; DNA Probes; DNA-Binding Proteins; Drosophila melanogaster; HeLa Cells; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Molecular Sequence Data; Nuclear Proteins; Phosphoglycerate Kinase; Phosphoric Monoester Hydrolases; Transcription Factors

1996
Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes.
    Journal of cellular physiology, 1996, Volume: 168, Issue:2

    Topics: Animals; Catalase; Cell Hypoxia; Cells, Cultured; Cobalt; Cycloheximide; Deferoxamine; DNA-Binding Proteins; Erythropoietin; Gene Expression Regulation; Hydrogen Peroxide; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Liver; Male; Nuclear Proteins; Oxygen; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; RNA; Signal Transduction; Transcription Factors

1996
Converse modulation of IRP1 and IRP2 by immunological stimuli in murine RAW 264.7 macrophages.
    The Journal of biological chemistry, 1998, Apr-17, Volume: 273, Issue:16

    Topics: Animals; Cell Line; Coculture Techniques; Cycloheximide; Deferoxamine; Enzyme Induction; Interferon-gamma; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Kinetics; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Receptors, Transferrin; Recombinant Proteins; RNA-Binding Proteins; T-Lymphocytes; Tumor Necrosis Factor-alpha

1998
Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication.
    The Biochemical journal, 1998, May-15, Volume: 332 ( Pt 1)

    Topics: Cell Division; Cell Line; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; Deferoxamine; DNA Damage; DNA Replication; Flow Cytometry; G1 Phase; Gene Expression Regulation; Humans; Hydrogen Peroxide; Papillomaviridae; Phosphorylation; Retinoblastoma Protein; Tumor Suppressor Protein p53; Viral Proteins

1998
Ribosome association contributes to restricting mRNAs to the cell body of hippocampal neurons.
    Molecular and cellular neurosciences, 1998, Volume: 12, Issue:6

    Topics: Actins; Animals; Biological Transport; Blotting, Northern; Cells, Cultured; Chelating Agents; Cycloheximide; Deferoxamine; Dendrites; Ferritins; Hippocampus; In Situ Hybridization; Neurons; Protein Synthesis Inhibitors; Puromycin; Rats; Ribosomes; RNA, Messenger

1998
Regulation of erythropoietin gene expression depends on two different oxygen-sensing mechanisms.
    Molecular genetics and metabolism, 1999, Volume: 67, Issue:2

    Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cycloheximide; Deferoxamine; Erythropoietin; Gene Expression Regulation; Humans; Oxygen; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured

1999
Physiological amounts of ascorbate potentiate phorbol ester-induced nuclear-binding of AP-1 transcription factor in cells of macrophagic lineage.
    Free radical biology & medicine, 2001, Aug-01, Volume: 31, Issue:3

    Topics: Animals; Ascorbic Acid; Cell Line; Cell Nucleus; Cycloheximide; Deferoxamine; Dimerization; Drug Synergism; Macrophages; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidation-Reduction; Protein Subunits; Proto-Oncogene Proteins c-jun; Tetradecanoylphorbol Acetate; Transcription Factor AP-1

2001
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Constriction; Cycloheximide; Deferoxamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Erythropoietin; Gene Expression; Glucose; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neurons; Nuclear Proteins; Oxygen; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors

2002
Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes.
    Brain research, 2002, Jul-19, Volume: 944, Issue:1-2

    Topics: Anti-Inflammatory Agents; Astrocytes; Brain; Cells, Cultured; Cycloheximide; Deferoxamine; Dexamethasone; Dose-Response Relationship, Drug; Endothelial Growth Factors; Gene Expression Regulation; Humans; Hypoxia, Brain; Iron Chelating Agents; Lymphokines; Nerve Degeneration; Neurons; Platelet Activating Factor; Protein Synthesis Inhibitors; RNA, Messenger; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002
Regulation of heme oxygenase-1 gene expression by anoxia and reoxygenation in primary rat hepatocyte cultures.
    Experimental biology and medicine (Maywood, N.J.), 2003, Volume: 228, Issue:5

    Topics: Allopurinol; Animals; Antioxidants; beta Carotene; Cell Hypoxia; Cells, Cultured; Cycloheximide; Dactinomycin; Deferoxamine; Free Radical Scavengers; Gene Expression Regulation, Enzymologic; Glutathione; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hepatocytes; HSP70 Heat-Shock Proteins; Iron Chelating Agents; Male; Oxygen; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion Injury

2003
Regulation of c-myc gene by nitric oxide via inactivating NF-kappa B complex in P19 mouse embryonal carcinoma cells.
    The Journal of biological chemistry, 2003, Aug-08, Volume: 278, Issue:32

    Topics: Animals; Cell Line; Chromatin; COS Cells; Cycloheximide; Deferoxamine; Dimerization; Dithiothreitol; DNA; Gene Expression Regulation; Gene Silencing; Genes, myc; Histones; Humans; Iron Chelating Agents; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Peroxynitrous Acid; Plasmids; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-myc; RNA, Messenger; Time Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured

2003
Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts.
    The Journal of investigative dermatology, 2003, Volume: 121, Issue:5

    Topics: Adult; Cell Hypoxia; Cells, Cultured; Cycloheximide; Dactinomycin; Deferoxamine; Female; Fibroblasts; Gene Expression Regulation; Half-Life; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Keloid; Male; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; RNA, Messenger; Transcription Factors

2003
Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate.
    Journal of neurochemistry, 2004, Volume: 88, Issue:5

    Topics: Animals; Astrocytes; Cell Survival; Cells, Cultured; Cycloheximide; Deferoxamine; Ferric Compounds; Ferritins; Iron; Iron Chelating Agents; L-Lactate Dehydrogenase; Protein Synthesis Inhibitors; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, Transferrin

2004
Post-transcriptional regulation of plasminogen activator inhibitor-1 by intracellular iron in cultured human lung fibroblasts--interaction of an 81-kDa nuclear protein with the 3'-UTR.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:5

    Topics: 3' Untranslated Regions; Antigens; Blotting, Northern; Cell Membrane; Cell Nucleus; Cells, Cultured; Cross-Linking Reagents; Culture Media, Conditioned; Cycloheximide; Cytoplasm; Deferoxamine; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Fibrinolysin; Fibroblasts; Humans; Iron; Lung; Plasmids; Plasminogen Activator Inhibitor 1; Protein Biosynthesis; RNA Processing, Post-Transcriptional; RNA, Messenger; Time Factors; Transcription, Genetic; Ultraviolet Rays; Wound Healing

2005
Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells.
    Apoptosis : an international journal on programmed cell death, 2005, Volume: 10, Issue:4

    Topics: Acids; Animals; Antioxidants; Apoptosis; Caspase Inhibitors; Cathepsins; Cell Line, Tumor; Cycloheximide; Deferoxamine; Enzyme Activation; Enzyme Inhibitors; Intracellular Space; Iron; Liver Neoplasms, Experimental; Lysosomes; Mitochondria; Rats; Tumor Necrosis Factor-alpha

2005
Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Oral oncology, 2007, Volume: 43, Issue:6

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cycloheximide; Deferoxamine; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Free Radical Scavengers; Genes, fos; Genes, jun; Humans; Imidazoles; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Photochemotherapy; Photosensitizing Agents; Porphyrins; Protein Synthesis Inhibitors; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Siderophores; Vascular Endothelial Growth Factor A

2007
Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes.
    European journal of pharmacology, 2010, May-10, Volume: 633, Issue:1-3

    Topics: Animals; Astrocytes; Cell Survival; Cells, Cultured; Cycloheximide; Cytoprotection; Deferoxamine; Drug Interactions; Enzyme Inhibitors; Hydrogen Peroxide; Hydroxybenzoates; Hypoxia-Inducible Factor 1; Indazoles; Mice; Oxidative Stress; Signal Transduction; Vascular Endothelial Growth Factor A

2010
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells.
    International immunopharmacology, 2013, Volume: 17, Issue:1

    Topics: Anthracenes; Antioxidants; Apoptosis; Butylated Hydroxyanisole; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Chelating Agents; Cycloheximide; Deferoxamine; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; RNA Interference; RNA, Small Interfering; Signal Transduction; Tumor Necrosis Factor-alpha; Vitamin E

2013
The role of cellular iron deficiency in controlling iron export.
    Biochimica et biophysica acta. General subjects, 2021, Volume: 1865, Issue:3

    Topics: Cation Transport Proteins; Cycloheximide; Deferoxamine; Gene Expression Regulation; HeLa Cells; Hepcidins; Humans; Ion Transport; Iron Chelating Agents; Iron Deficiencies; Protein Binding; Protein Synthesis Inhibitors; Protein Transport; Proteolysis; Signal Transduction

2021